NatureCell Co.Ltd (007390) - Total Liabilities

Latest as of September 2025: ₩8.60 Billion KRW ≈ $5.83 Million USD

Based on the latest financial reports, NatureCell Co.Ltd (007390) has total liabilities worth ₩8.60 Billion KRW (≈ $5.83 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

NatureCell Co.Ltd - Total Liabilities Trend (2009–2024)

This chart illustrates how NatureCell Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of NatureCell Co.Ltd to evaluate short-term liquidity relative to the company's equity base.

NatureCell Co.Ltd Competitors by Total Liabilities

The table below lists competitors of NatureCell Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Zenas BioPharma, Inc. Common Stock NASDAQ:ZBIO	USA	$411.85 Million
RITES Limited NSE:RITES	India	Rs33.18 Billion
PORR AG VI:POS	Austria	€3.57 Billion
Shenzhen Strongteam Decoration Engineering Co Ltd SHE:002989	China	CN¥737.49 Million
Gentherm Inc NASDAQ:THRM	USA	$713.82 Million
Jubilant Ingrevia Limited NSE:JUBLINGREA	India	Rs22.16 Billion
Shandong Fengyuan Chemical Co Ltd SHE:002805	China	CN¥4.26 Billion
Jasa Marga Tbk JK:JSMR	Indonesia	Rp97.08 Trillion

Liability Composition Analysis (2009–2024)

This chart breaks down NatureCell Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 007390 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.91	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NatureCell Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NatureCell Co.Ltd (2009–2024)

The table below shows the annual total liabilities of NatureCell Co.Ltd from 2009 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩7.37 Billion ≈ $5.00 Million	+5.64%
2023-12-31	₩6.98 Billion ≈ $4.73 Million	-81.07%
2022-12-31	₩36.86 Billion ≈ $24.98 Million	+318.67%
2021-12-31	₩8.80 Billion ≈ $5.97 Million	-61.83%
2020-12-31	₩23.07 Billion ≈ $15.63 Million	+105.57%
2019-12-31	₩11.22 Billion ≈ $7.60 Million	+15.13%
2018-12-31	₩9.75 Billion ≈ $6.61 Million	-18.50%
2017-12-31	₩11.96 Billion ≈ $8.10 Million	-35.87%
2016-12-31	₩18.65 Billion ≈ $12.64 Million	+30.57%
2015-12-31	₩14.28 Billion ≈ $9.68 Million	+32.39%
2014-12-31	₩10.79 Billion ≈ $7.31 Million	-52.51%
2010-12-31	₩22.72 Billion ≈ $15.39 Million	-18.94%
2009-12-31	₩28.02 Billion ≈ $18.99 Million	--

About NatureCell Co.Ltd

KQ:007390 Korea Pharmaceuticals

Market Cap

$1.10 Billion

₩1.63 Trillion KRW

Market Cap Rank

#8654 Global

#233 in Korea

Share Price

₩30650.00

Change (1 day)

-4.81%

52-Week Range

₩16900.00 - ₩37800.00

All Time High

₩58126.80